Drugs / house dust mite extract
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00652223 Background | Mar → Nov 2005 | allergic asthma, perennial allergic rhinitis | Cytos Biotechnology AG | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | house dust mite extract | “Immunomodulator CYT003-QbG10 in combination with commercial house dust mite extract as used for routine SIT” NCT00652223 ↗ |